References
- . Mandell LA, Wunderink RG, Anzueto A,. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44( suppl 2):S27–S72
- . Echols RM, Tillotson GS, Song JX, Tosiello RL. Clinical trial design for mild-to-moderate community-acquired pneumonia—an industry perspective. Clin Infect Dis. 2008;47( suppl 3):S166–S175
- . Jenkins SG, Brown SD, Farrell DJ. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1–4. Ann Clin Microbiol Antimicrob. 2008;7:1–11
- . Doern GV, Richter SS, Miller A,. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis. 2005;41(2):139–148
- . Peterson L. Penicillins for the treatment of pneumococcal pneumonia: does in vitro resistance really matter? Clin Infect Dis. 2006;42(2):224–233
- . Lujan M, Gallego M, Fontanals D, Mariscal D, Rello J. Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality. Crit Care Med. 2004;32(3):625–631
- . Daneman N, McGeer A, Green K, Low DE; Toronto Invasive Bacterial Diseases Network. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis. 2006; 43(4):432–438
- . Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A; Toronto Invasive Bacterial Disease Network. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis. 2005;40(9):1288–1297
- . Doern GV, Richter SS, Miller A,. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis. 2005;41(2):139–148